Malignant pleural mesothelioma classification and survival prediction with CT imaging using ResNet

December 5, 2025 | Comments Off on Malignant pleural mesothelioma classification and survival prediction with CT imaging using ResNet

European Radiology 2025 October 30 [Link] Meng Zhou, Minghua Li, Qian Cao, Zhen Zhang, Leonard Wee, Andre Dekker, Ji Zhu, Haitao Jiang, Jiapeng Jiang, Xinyu Miao, Weimin Mao, Meng Yan,…

Risk factors, prognostic factors, and nomograms for distant metastasis in patients with malignant pleural mesothelioma: A population-based retrospective study

December 4, 2025 | Comments Off on Risk factors, prognostic factors, and nomograms for distant metastasis in patients with malignant pleural mesothelioma: A population-based retrospective study

The Journal of International Medical Research 2025 October [Link] Quzhe Lu, Chao Liu, Meixiang Xu, Zhi Hu, Hui Yin, Jie Yang Abstract Objectives Malignant pleural mesothelioma is a rare and…

Malignant pleural mesothelioma classification and survival prediction with CT imaging using ResNet

December 3, 2025 | Comments Off on Malignant pleural mesothelioma classification and survival prediction with CT imaging using ResNet

European Radiology 2025 October 30 [Link] Meng Zhou, Minghua Li, Qian Cao, Zhen Zhang, Leonard Wee, Andre Dekker, Ji Zhu, Haitao Jiang, Jiapeng Jiang, Xinyu Miao, Weimin Mao, Meng Yan,…

Narciclasine as a Novel Treatment for Lung Cancer and Malignant Pleural Mesothelioma: Insights from 3D Tumor Spheroid Models

December 2, 2025 | Comments Off on Narciclasine as a Novel Treatment for Lung Cancer and Malignant Pleural Mesothelioma: Insights from 3D Tumor Spheroid Models

International Journal of Molecular Sciences 2025 October 17 [Link] Sicong Jiang, Serkan Berkcan, Nadja Perriraz-Mayer, Frédéric Triponez, Véronique Serre-Beinier Abstract Thoracic tumors, including lung adenocarcinoma (LUAD) and malignant pleural mesothelioma…

Use of Patient-Derived Organoids for Pleural Mesothelioma 3D modelling

December 1, 2025 | Comments Off on Use of Patient-Derived Organoids for Pleural Mesothelioma 3D modelling

American Journal of Physiology Lung Cellular and Molecular Physiology 2025 October 29 [Link] Luca Volpini, Federica Monaco, Elisabetta Casalone, Elton Jalis Herman, Rebecca Filomena, Sandra Manzotti, Olga Strogovets, Gianluca Moroncini,…

Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression

November 21, 2025 | Comments Off on Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression

Cells 2025 October 15 [Link] Luca Hegedüs, Silvia Qaisieh, Christian Stülpnagel, Yavar Ganjeh Khor Dezfouli, Winny Tambo, Fabian Doerr, Natalie Baldes, Dirk Theegarten, Martin Schuler, Servet Bölükbas, Balazs Hegedüs Abstract…

Narciclasine as a Novel Treatment for Lung Cancer and Malignant Pleural Mesothelioma: Insights from 3D Tumor Spheroid Models

November 20, 2025 | Comments Off on Narciclasine as a Novel Treatment for Lung Cancer and Malignant Pleural Mesothelioma: Insights from 3D Tumor Spheroid Models

International Journal of Molecular Sciences 2025 October 17 [Link] Sicong Jiang, Serkan Berkcan, Nadja Perriraz-Mayer, Frédéric Triponez, Véronique Serre-Beinier Abstract Thoracic tumors, including lung adenocarcinoma (LUAD) and malignant pleural mesothelioma…

Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies

November 19, 2025 | Comments Off on Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies

Advanced Science 2025 October 24 [Link] Yan Sun, Haochen Yang, Qing Xu, Xingya Li, Jinxing Lou, Jianchun Duan, Jiachen Xu, Zhuqing Liu, Yong Xia, Zhicai Lin, Linlin Li, Dan Sun,…

PD-L1 expression as a prognostic factor for postoperative outcomes in pleural mesothelioma

November 18, 2025 | Comments Off on PD-L1 expression as a prognostic factor for postoperative outcomes in pleural mesothelioma

Translational Lung Cancer Research 2025 September 30 [Link] Masatoshi Kanayama, Takehiko Manabe, Katsuma Yoshimatsu, Yukiko Nemoto, Hiroki Matsumiya, Masataka Mori, Masaru Takenaka, Koji Kuroda, Fumihiro Tanaka Abstract Background: Pleural mesothelioma…

Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma

November 17, 2025 | Comments Off on Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma

Clinical Medicine Insights Oncology 2025 October 17 [Link] Doğan Bayram, Safa Can Efil, Serap Türk, Oğuz Kara, Serhat Sekmek, Şebnem Yücel, Selin Aktürk Esen, Gökhan Uçar, Oznur Bal, Efnan Algin,…

Categories